Markets:

Overview

News

Currencies

International

Treasuries

Shockwave Medical, Inc. - Common Stock (NQ:SWAV)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Shockwave Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

7 Overlooked Stocks That Belong in Every Portfolio ↗

June 03, 2024

Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks.

Via InvestorPlace

Why Sarepta Therapeutics Stock Is Rising Today ↗

May 30, 2024

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400.

Via Benzinga

Topics Stocks

Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M ↗

May 16, 2024

Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated diseases.

Via Benzinga

SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV

May 09, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Exploring the Growth Potential of NASDAQ:SWAV as It Nears a Breakout. ↗

May 09, 2024

SHOCKWAVE MEDICAL INC (NASDAQ:SWAV), a strong growth stock, setting up for a breakout.

Via Chartmill

NASDAQ:SWAV: a strong growth stock preparing for the next leg up?. ↗

April 17, 2024

Is SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

SWAV Stock Earnings: ShockWave Medical Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

SWAV stock results show that ShockWave Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Shockwave Medical Reports First Quarter 2024 Financial Results

May 06, 2024

From Shockwave Medical, Inc.

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical,

May 06, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

May 01, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Johnson & Johnson Is a King of Dividend Safety ↗

April 29, 2024

The healthcare behemoth has fortified its dividend.

Via The Motley Fool

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024 ↗

April 25, 2024

The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch.

Via InvestorPlace

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)

April 22, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now. ↗

April 18, 2024

Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.

Via InvestorPlace

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff ↗

April 16, 2024

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost...

Via Benzinga

April 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)

April 15, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

MarketBeat Week in Review – 4/8 - 4/12

April 13, 2024

The latest inflation readings moved stocks lower as investors reconsidered what higher-for-longer interest rates mean for corporate earnings and stock valuation

Via MarketBeat

Topics Economy

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024 ↗

April 11, 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

Via InvestorPlace

All-Time High Flyers: 7 Stocks to Buy as the Market Peaks ↗

April 11, 2024

These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.

Via InvestorPlace

5 Things To Know In Investing This Week - The Shockwave Takeover Issue ↗

April 11, 2024

The Shockwave offer that DKI predicted in December happened this week with Johnson & Johnson (NYSE: JNJ)agreeing to pay $335 per share in cash. DKI subscribers celebrated! The PMI came in hot. Don’t...

Via Benzinga

Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024 ↗

April 10, 2024

These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.

Via InvestorPlace

Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy? ↗

April 10, 2024

The company is hoping to expand, but is there enough here to attract growth investors?

Via The Motley Fool

3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade ↗

April 09, 2024

Income-seeking investors can look forward to steady payout raises from these pharma stocks.

Via The Motley Fool

SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV

April 08, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study

April 08, 2024

Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina

From Shockwave Medical, Inc.

Via GlobeNewswire

Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says ↗

April 08, 2024

Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a strategic shift, with around $30 billion invested in MedTech over 18 months.

Via Benzinga

April 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?

April 08, 2024

Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend

Via MarketBeat

Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday ↗

April 08, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.